Povidone-Iodine 10% Inclusion In Vaginal Drug Products Unsupported – FDA
This article was originally published in The Tan Sheet
Executive Summary
Products for the relief of minor vaginal itching and irritation containing povidone-iodine 10% are unnecessary due to acceptable lower concentrations of the ingredient, FDA says in response to a citizen petition submitted by The Purdue Frederick Company
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning